Ibaraki, Japan

Masashi Kishida


Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
4 patents (USPTO):

Title: Masashi Kishida: Innovator in Pharmaceutical Chemistry

Introduction

Masashi Kishida is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific health conditions. With a total of four patents to his name, Kishida's work is recognized for its potential impact on medical treatments.

Latest Patents

Kishida's latest patents include innovative compounds known as bicyclic derivatives that serve as CETP inhibitors. These compounds are designed to be used in pharmaceutical compositions aimed at treating or delaying the progression of diseases associated with CETP. The detailed formula and variables of these compounds are defined in the patent text, showcasing the complexity and specificity of his inventions.

Career Highlights

Throughout his career, Masashi Kishida has been associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. Kishida's dedication to innovation has positioned him as a key figure in the industry.

Collaborations

Kishida has collaborated with notable colleagues such as Junichi Sakaki and Naoko Matsuura. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to more effective solutions in pharmaceutical chemistry.

Conclusion

Masashi Kishida's contributions to the field of pharmaceutical chemistry through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments, demonstrating the vital role of inventors in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…